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Abstract
Background: In resource-constrained health systems medical travel is a common alternative to seeking unavailable
health services. This paper was motivated by the need to understand better the impact of such travel on
households and health systems.
Methods: We used primary data from 344 subsidized and 471 non-subsidized inbound medical travellers during
June to December 2013 drawn from the North, Centre and South regions of the Maldives where three international
airports are located. Using a researcher-administered questionnaire to acquire data, we calculated annual out-of-
pocket (OOP) spending on health, food and non-food items among households where at least one member had
travelled to another country for medical care within the last year and estimated the poverty head count using
household income as a living standard measure.
Results: Most of the socio demographic indicators, and costs of treatment abroad among Maldivian medical
travellers were similar across different household income levels with no statistical difference between subsidized
and non-subsidized travellers (p value: 0.499). The government subsidy across income quintiles was also similar
indicating that the Maldivian health financing structure supports equality rather than being equity-sensitive. There
was no statistical difference in OOP expenditure on medical care abroad and annual OOP expenditure on
healthcare was similar across income quintiles. Diseases of the circulatory system, eye and musculoskeletal system
had the most impoverishing effect – diseases for which half of the patients, or less, did not receive the public
subsidy. Annually, 6 and 14% of the medical travellers in the Maldives fell into poverty ($2 per day) before and after
making OOP payments to health care.
Conclusion: Evidence of a strong association between predominant public financing of medical travel and equality
was found. With universal eligibility to the government subsidy for medical travel, utilization of treatment abroad,
medical expenditures abroad and OOP expenditures on health among Maldivian medical travellers were similar
between the poor and the rich. However, we conclude mixed evidence on the linkages between public financing
of medical travel and impoverishment which needs to be further explored with comparison of impoverishment
levels between households with and without medical travel.
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Background
Eradicating poverty and inequality is one of the funda-
mentals of the Sustainable Development Goals (SDGs).
The World Health Organization (WHO) estimates that
a hundred million people are pushed into poverty as a
result of payments to health care and a billion people
suffer each year because they cannot access the health
care they need [1]. Medical travel can help people ac-
quire health services inaccessible in the domestic health
system because of long waiting times, legal restrictions,
cost of care or simply because of unavailability of the
service. Although much of the demand for medical
travel comes from the rich, ease of travel, targeted insur-
ance packages and comparatively cheap prices offered by
destination countries have lured the less wealthy into
this industry. For example, one study of external oppor-
tunities and threats, and internal organizational
strengths and weaknesses of Asian medical travel desti-
nations, found that low-cost was a common selling point
of medical travel destinations, while India especially po-
sitioned itself as providing a more holistic approach to
medical services [2].
Out-of-pocket (OOP) payments to health care have
shown to be high among vulnerable population groups
such as migrants [3], specific disease groups [4] and in
conflict areas [5]. OOP spending is widely believed to be
a poor way to finance health care as it falls dispropor-
tionately on the most vulnerable, when they often need
the service the most [6]. On the other hand, government
financing of health care and public infrastructure in the
health system has shown to be a protective factor in re-
ducing impoverishment [7]. Medical travelers fall out of
both of these protection measures as most medical tour-
ism services are provided by private health facilities and
financial protection is limited for services sought out of
the local health system or the public health system. Even
where overseas treatment is subsidized by governments,
much of the indirect costs are borne by the households.
Empirical evidence on the payments to healthcare and
its impact on this group of people who seek health care
across borders are lacking.
In this paper, we explored the situation in the Maldives
where universal health care (UHC), through a subsidy
for treatment abroad for selected diseases, has been in
place since 2012. Under the Nation Social Health Insur-
ance Act (2011) the National Social Protection Agency
(NSPA) is mandated to provide free healthcare for all
Maldivians. The public subsidy is provided for direct
medical costs for a pre-approved set of services available
in the country. Health services sought outside the coun-
try under the scheme have to be sanctioned by a public
sector physician. According to health financing by func-
tion, the National Health Accounts of the Maldives 2011
showed that the largest proportion of health finance was
spent on foreign providers (23.7%). Being an import-
oriented economy, the Maldives imports health profes-
sionals, medical equipment, medical consumables and
medical education, and travel for medical treatment is
common. The Maldivians Travelling Abroad Survey
2013 by the Central Bank of the Maldives indicated that
half of all Maldivians travelled abroad (MTA) for differ-
ent purposes, spending a total of US$191 million in out-
bound travel [8]. More than 50% of this expenditure was
for medical treatment abroad according to the 2016
MTA Survey. We analyzed consumption patterns of
medical travelers and compared the percentage of med-
ical travelers that fall into poverty annually between a
sample of subsidized travelers and non-subsidized trav-
elers. We focused on measuring equality of treatment of
all with respect to public subsidy for medical travel in-
stead of equity which promotes fairness. Findings from
this study will guide countries facing similar problems of
limited capacity or lack of economies of scale in ways to
alleviate poverty due to health care payments.
Methods
Study design
The data are derived from a cross-sectional survey of in-
bound Maldivian patients who travelled for medical
treatment during the period June–December 2013.
Study setting
The study was undertaken in the Republic of Maldives,
situated in the Indian Ocean, and neighboring Sri Lanka
and India – the two countries that the majority of Mal-
divian medical travelers frequent [8]. At the time of the
study, three international airports (one in the North,
Center and South) were the exit points for travel abroad.
Figure 1 shows the data collection points on the map of
the Maldives.
Sample size
A minimum sample-size of 342 subsidized and 473 non-
subsidised travellers was calculated as required to esti-
mate expenditures with a precision of at most 5% differ-
ence from the average actual expenditure in each group
and with the assumption of a 30% non-response rate.
During the study period, we were able to interview 344
subsidised and 471 non subsidised travellers who were
included in the analysis.
Sampling
We used multiple sources to reach medical travellers.
Subsidised travellers were recruited from the database of
medical travellers maintained by the government of the
Maldives. Among 2556 subsidized patients who travelled
during the study period, 344 were randomly selected
and a telephone interview was conducted. Non-
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subsidized travellers were recruited by surveying the
three international airports of Maldives (Hanimaadhoo
international airport in the North, Ibrahim Nasir inter-
national airport in the central region and Gan inter-
national Airport in the south) and the regional health
facility in each of the three regions. Face-to-face inter-
views were conducted with a consecutive sample of 335
travellers at the airports while telephone interviews were
conducted with 136 available travellers contacted from
the lists of referrals abroad at the regional health facil-
ities. A total of 473 self-funded patients were inter-
viewed by the end of the study period.
Study sample
There were subsidized and non-subsidized cases. A sub-
sidized patient was defined as one if any part of his/her
expenses for medical travel was provided by the govern-
ment. Proxies were allowed for the elderly, young or
very ill patients. Traditional medicine centers and facil-
ities not registered as a health facility in the destination
country were excluded.
Data collection
Data were collected from August to December 2013. All
815 participants recruited from all the sources were inter-
viewed using a common questionnaire which was pre-
tested and researcher-administered. The questionnaire
was translated into the local language (Dhivehi) and offi-
cial approval for the translation was sought from the
Ministry of Education of Maldives. Data on demographic
and household characteristics, monthly OOP household
expenditures, disease profile and costs of the last medical
travel episode were collected.
Data management
All monetary values were expressed in purchasing
power parity (PPP) dollars at the conversion rate of
11.1 Mrf per PPP dollar for the year 2013. [9] The
PPP conversion factor is the number of units of a
country’s currency required to buy the same amount
of goods and services in the domestic market as a
U.S. dollar would buy in the United States [10]. The
PPP exchange rate was used throughout the analysis
as it helps to minimize misleading international
Fig. 1 Data collection points on the map of Maldives
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comparisons that normally arise with the use of mar-
ket exchange rates. Monthly household income was
used as a living standard measure in the study.
Monthly household income was grouped into quin-
tiles among the subjects.
The main components of the consumption aggregate
include monthly OOP expenses for health, food and
non-food expenses multiplied by 12 to derive annual
consumption aggregates. Health payments comprise of
sub-aggregates for both local expenses and medical ex-
penses born during the last episode of medical treatment
abroad multiplied by the number of visits each year.
Likewise food and non-food expenses born during the
medical travel episode were represented in the respective
sub aggregates. Food consumption includes purchases
made from income sources, while non-food consump-
tion includes items such as clothing, education, travel,
rent energy. Following standard practice, lumpy expendi-
tures such as consumer durable goods, constructions,
fines and debt were excluded.
The primary diagnosis for which treatment was
sought abroad was coded under the 22 major group-
ings of ICD 10, version 2010. Ailments or descrip-
tions that did not fall under any major disease group
were coded under “Factors influencing health status
and contact with health services” (Z00-Z99 of ICD10).
One hundred and sixty nine observations in this
group consisting of 65 subsidized and 104 non-
subsidized travelers were omitted in the analysis of
the disease profile, following WHO advice not to use
this group for comparisons. [11] To measure disease
specific impoverishment, diseases were sorted by the
median medical cost of treatment and the top five
diseases were analyzed.
Residential atolls of the travelers were first grouped
into the 7 administrative provinces and were regrouped
by collapsing the Upper North and North provinces into
North region, North central and central province into
Central region and South central, Upper south and
South provinces in to South region. Regrouping was
done to manage the small number of records at province
level that did not allow for proper analysis.
Statistical analysis
The household was the unit of analysis in this study.
Data analysis was conducted using the open source R
software, version 3.1.0 [12]. We measured both inequal-
ity and poverty. Inequality measurements include basic
dispersion measures such as the Pen’s Parade, percentile
ratio, consumption share of the poorest using frequency
distribution across quintiles. Non-parametric tests were
used to identify differences in the patterns and the level
of significance was set at p < 0.05. As annual income was
ranked into quintiles and did not follow normality, the
Kruskal Wallis test, chi-square test and the Ranksum
test were used to allow analysis against other nominal
values. For the analysis of impoverishment, we used the
international poverty lines of $2. Poverty head count1
and poverty gap2 were measured following O’Donnell et
al. [13].
If xi is the household i’s consumption per capita,
pgrossi =1, if xi < the poverty line, and p
gross
i =0, if
otherwise.
The Gross poverty head count and gross poverty gap
is expressed as
Hgross ¼
XN
i¼1sip
gross
i =
XN
i¼1si
Ggross ¼
XN
i¼1sig
gross
i =
XN
i¼1si
Where si is the size of the household, N is the number
of households in the sample and ggross = pgrossi (poverty
line- xi). The net of health payments poverty gap g
net =
pneti (poverty line–(xi − Ti)), where Ti is the per capita
out of pocket spending on health.
The impact of poverty was derived by assessing the
difference between gross and net of OOP payments to
health care in each of the above measures.
Poverty head count ¼ Hgross−Hnet
Poverty gap ¼ Ggross−Gnet
Jan Pen’s parade [13] .for household expenditures
gross and net of OOP payments to health care was used
to plot health adjusted impoverishment among house-
holds of medical travelers. The international poverty line
of $2 per day was used to define poverty on the parades.
The effect of health payments on the Pen’s Parade of per
capita household expenditure was illustrated using the
‘Paint drip’ chart. Each “paint drip,” represents a house-
hold showing the extent to which the subtraction of
health payments reduces consumption. A bar that
crosses the poverty line implies that a household is not
counted as poor on the basis of gross consumption but
is poor on the basis of net consumption [13]
Results
Table 1 shows the utilization of medical travel across in-
come quintiles. Medical travelers were mostly from the
middle-income group (Quintile 3) with no statistical dif-
ference between subsidized and non-subsidized travelers
(p value: 0.499). Among regions, the number of medical
travelers was lowest among the poorest people in the
Central region, while in both North and South regions,
the share of the poorer quintile was highest. Most of the
travelers had ownership of their homes, while of people
living in rented housing the poorer people were less
likely to travel abroad (p value: 0.001). Among the
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poorest quintile, travel was most common among
smaller families.
Table 2 shows that medical expenditure abroad was
similar across all income quintiles (p value: 0.95). There
was no statistical difference in OOP expenditures on
medical purposes abroad and annual OOP expenditure
on health was similar across income quintiles. The gov-
ernment subsidy across income quintiles was also similar
indicating that the health financing structure is not pro
poor. Expenditure on food and non-food items was
Table 1 Utilization of medical travel across income quintiles
Indicator Q1 Q2 Q3 Q4 Q5 overall p value Ratio of
Q1:Q5
All travelers 172 154 227 137 125 815
Financial protection 0.499
Subsidized travelers (N = 344) 81 (23.5) 65 (18.9) 93 (27) 59 (17.2) 46 (13.4) 344 (100) 1.8
Non subsidized travelers (N= 471) 91 (19.3) 89 (18.9) 134 (28.5) 78 (16.6) 79 (16.8) 471 (100) 1.1
Region of residence < 0.001
Central region N = 366 40 (10.9) 57 (15.6) 106 (29) 80 (21.9) 83 (22.7) 366 (100) 0.5
North region N = 245 69 (28.2) 54 (22) 71 (29) 27 (11) 24 (9.8) 245 (100) 2.9
South region N = 204 63 (30.9) 43 (21.1) 50 (24.5) 30 (14.7) 18 (8.8) 204 (100) 3.5
Type of tenure < 0.001
Rent free N = 63 17 (27) 13 (20.6) 20 (31.7) 9 (14.3) 4 (6.3) 63 (100) 4.3
Rented N = 147 7 (4.8) 23 (15.6) 55 (37.4) 41 (27.9) 21 (14.3) 147 (100) 0.3
Owner occupied N = 605 148 (24.5) 118 (19.5) 152 (25.1) 87 (14.4) 100 (16.5) 605 (100) 1.5
Household size < 0.001
Small (≤5 members) 131 (27.4) 91 (19) 146 (30.5) 65 (13.6) 45 (9.4) 478 (100) 2.9
Medium (6–10 members) 38 (15.3) 46 (18.5) 68 (27.3) 52 (20.9) 45 (18.1) 249 (100) 0.8
Large (> 10 members) 3 (3.4) 17 (19.3) 13 (14.8) 20 (22.7) 35 (39.8) 88 (100) 0.1
Length of stay (Median, IQR) 12.5 (9.8,19) 15 (10,20) 15 (10,20) 14 (10,21) 12 (10,21) 14 (10,20) 0.356 1.0
Number of visits (Median, IQR) 1 (1,1.2) 1 (1,2) 1 (1,1) 1 (1,2) 1 (1,1) 1 (1,1) 0.374 1.0
Age (Median, IQR) 48 (36,62) 40.5 (21.2,50) 40 (27.5,53) 37 (20,50) 42 (22,55) 42 (25,54) < 0.001 1.6
Note: P values are from Kuskal-Wallis and chi squared tests
Table 2 Expenditure inequalities among medical travelers
Indicator Income quintiles p value
(between
quintiles)
Q1 Q2 Q3 Q4 Q5 Overall
Total (N) 172 154 227 137 125 815
Medical expenditure abroad
(USD PPP)
670.4
(268.2,1566.8)
670.4
(257.4,1340.9)
603.4
(223.9,1633.8)
626.2 (205.2,1475) 536.3
(211.9,1340.9)
670.4 (243.4,1542) 0.952
Non-medical expenditure
abroad (USD PPP)
2274.8
(1644.2,3111.8)
2516.8
(1794.8,4062.8)
2695.1
(1749.2,4026.6)
2449.8
(1652,3531.9)
2650.9
(1717.7,3763.8)
2481.9
(1711.6,3731.6)
0.025
OOP medical expenditure
abroad (USD PPP)
321.1 (64,927.5) 293 (59,804.5) 272.2 (67,804.5) 348.6 (101.9914.5) 284.3 (73.7804.5) 295 (67,871.6) 0.984
Medical expenditure by
government abroad
(USD PPP)
0 (0,268.2) 0 (0,477.7) 0 (0,592.7) 0 (0,434.4) 0 (0,234.7) 0 (0,418.4) 0.963
Annual OOP household
expenditure on health
(USD PPP)
1158.5
(473,2536.6)
1151.8
(512.9,3261.3)
1224.2
(431.8,2781)
1469.6
(690.5,3137.6)
1627.8
(429.1,3727.6)
1311.4
(513.6,3118.9)
0.369
Annual OOP household
expenditure on food
(USD PPP)
3372.3
(2364,4890.2)
5127.5
(3248.9,6527.4)
5261.6
(3719.6,8165.9)
6259.2
(3856.3,8595)
8418
(5571.3,11,126.5)
5213.3
(3381.7,7571.9)
< 0.001
Annual OOP household
expenditure on non-food
(USD PPP)
2543
(1527.3,4349.1)
3811.4
(2448.4,7327.2)
4081.6
(2677.7,8495.1)
5492.2
(2551.7,11,786.2)
4355.1
(2015.3,8887.3)
3810.8
(2174.2,7964.8)
< 0.001
Note: P values are from Kuskal-Wallis and Ranksum tests
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significantly different between the income quintiles, with
non-medical expenditure lowest in the poorest quintile
(p value: 0.025).
As Table 3 shows, the median cost of treatment was
highest among the patients who sought treatment for
neoplasms. The percentile ratio shows that for every dol-
lar spent by the poorest quintile on the treatment of
neoplasms, the richest quintile spent 114 dollars. The
impoverishment effect from neoplasms was found to be
very low compared to other diseases which may be
explained by the high proportion of people subsidized
for this treatment (86.3%), but the impoverishment effect
was lowest among the patients treated for diseases of the
nervous system (2%), for which only one third obtained
the public subsidy. Across all of the top five diseases, the
expenditure share of the poorest percentile was mark-
edly lower. Diseases of the circulatory system, eye and
musculoskeletal system had the most impoverishing
effect where only half or fewer of the patients had
received the subsidy.
Figure 2 shows the Pen’s Parade for household
expenditure before making OOP expenditures to health-
care, with the paint drips representing the effect on
expenditure for each household after making OOP pay-
ments to health. Annually 6 and 14% of medical travel-
lers in the Maldives fall into poverty (an income of less
than $2 per day) after making OOP payments to health
care. Distribution of health payments were found to be
proportionate to total consumption, with larger health
payments at higher values of total consumption and
smaller among the households in the lower half of the
distribution. Although expenditure on health is lower
among the households in the lower half of the distribu-
tion, they are the households most likely to be pushed
below the poverty line by health payments. The house-
hold expenditure net of health payments between subsi-
dised and non-subsidised patients indicated that 17% of
the subsidized travellers and 12% of the non-subsidised
patients fall below poverty line after making payments to
health care.
Discussion
Contrary to conclusions in much of the existing litera-
ture on medical travel, most of the socio demographic
indicators, and costs of treatment abroad among these
Maldivian medical travelers, were similar across different
household income levels [14–16]. Medical expenditure
abroad and OOP expenditures on health were consistent
among the poor and the rich irrespective of government
subsidy. This suggests that the Maldivian health finan-
cing structure supports equality rather than being
equity-sensitive. Study results pointed towards disease
specific inequalities and impoverishment among medical
travelers, where the expenditure share of the poorest
percentile was pointedly lower across all the top five dis-
eases. Although patients suffering from neoplasms bear
the highest cost of treatment abroad, the level of impov-
erishment was low. Disease groups which had the high-
est levels of impoverishment had only half of the
patients covered by the public subsidy. Yet, the disease
group with the lowest impoverishment level had only
one third of its patients covered by the public subsidy.
This indication of an association between the govern-
ment subsidy and impoverishment needs to be further
explored. Overall, the type of disease for which the
patient travelled seemed a greater predictor of impover-
ishment than the government subsidy. Study findings
also showed that more of the subsidized patients fell into
poverty compared to the non-subsidized which offers
important directions for the revision of the current
benefit package and to implement appropriate targeting
mechanisms. Taken together, these findings suggest that
the current government subsidy has little effect and does
not offer protection from impoverishment.
Utilization of medical travel was more common
among middle-income earners and the poorer quintiles
across both subsidized and non-subsidized travelers. The
predominant public financing for health care by the gov-
ernment of Maldives and availability of other sources of
insurance with specific targeting mechanisms for med-
ical travel may explain the pro poor utilization pattern.
Table 3 Dispersion ratio across the top five diseases among medical travelers, 2013
Disease Group (ICD 10) Medical cost during
last episode
of treatment abroad
Richest
5%
Poorest
5%
Percentile
ratio
Poverty head count
ratio
Proportion of
financial
protection
N Median (IQR) 95th
percentile
5th
percentile
Gross Net Difference %
Diseases of the circulatory system 82 926.54 (266, 2625) 12,128.9 124.7 97.3 3% 18% 16% 57.3
Diseases of nervous system 69 795.13 (305, 1474) 7237.2 127.9 56.6 0% 2% 2% 33.3
Diseases of musculoskeletal system 65 603.39 (218, 1072) 2111.9 73.2 28.8 6% 16% 10% 15.4
Diseases of genitourinary system 62 808.54 (305, 1331) 4009.2 67.1 59.7 10% 18% 8% 54.8
Diseases of the eye & adnexa 51 492.09 (156, 1149) 2136.0 52.3 40.8 17% 28% 11% 54.9
Neoplasms 51 1193.37 (412, 4312) 9589.2 83.8 114.4 2% 7% 5% 86.3
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By 2013, the government of the Maldives spent
744,921,545 MVR (approximately USD 48,308,790)
under the universal health care program ‘Aasandha’, and
an additional 40,484,849MVR (approximately USD
2,625,476) under the emergency medical welfare pro-
gram. Other large public institutions such as the police
service and the defense force offer health insurance for
their employees and their families [17]. Due to the pre-
dominance of public funding towards health coverage,
only three parties in the private sector targets the
remaining population with offers of medical travel
included [18].
The study findings contradict much of the existing
literature on medical travel which has highlighted the
possibility for inequalities in access created by medical
travel [19–23]. However, our findings are congruent
with the achievements of UHC experienced in Thailand
[24], Mexico [25] and Turkey [26] which has improved
access to the poor within the domestic health system.
This study provides support that a public funded UHC
can promote access to health services abroad for the
poor as well.
Medical expenditures abroad were similar across all
income quintiles of medical travelers and with no statis-
tical difference in OOP expenditures on medical pur-
poses abroad and annual OOP expenditure on health
across income quintiles. Distribution of the government
subsidy across income quintiles was also similar indicat-
ing that the health financing structure is not equity-
sensitive but focused on maintaining equality. The 2008
report of the WHO Commission on Social Determinants
of Health states that inequities in health results from the
unequal distribution of power, prestige and resources
[27]. According to the World Bank country snapshot of
March 2014, the Maldives endures a high level of
inequality at a national Gini-coefficient of 0.37 which
explains the government policy [28]. At the same time
the same country report highlights that almost a quarter
of the population (24%) lives below the international
poverty line of $2 per day and the study results are in
line with this as 14% of the travelers in the study were
impoverished after making payments to health care.
Study findings are suggestive that a balance of equality
and equity is important in order to improve access to
the whole population and maintain fairness.
We observed disease-specific inequalities and impov-
erishment among medical travelers. Across all the top
five diseases, the expenditure share of the poorest per-
centile was pointedly lower. The median cost of treat-
ment was highest among the patients who sought
treatment for neoplasms and the percentile ratio showed
that for every dollar spent by the poorest quintile on the
treatment of neoplasms, the rich spent 114 dollars. A
multivariate analysis that assessed the socioeconomic-
differentials in the impact of OOP expenditure on
impoverishment in China and India indicated that lower
standard of living increases the odds of falling below
poverty line significantly [29]. The findings direct policy
interventions to prioritize patients with lengthy and
costly treatments, based on socioeconomic indicators of
the patients. Diseases of the circulatory system, eye and
musculoskeletal system had the most impoverishing
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effect where only half or fewer of the patients had
received the subsidy. Future research questions need to
explore the reasons why people do not access govern-
ment subsidy and the reasons for the existence of
disease-specific impoverishment.
Impoverishment was found to be higher among the
subsidised travellers with 17% of the subsidized travellers
falling below poverty line after making payments to
health care compared to 12% of the non-subsidised pa-
tients. The current level of government investment and
current offer of subsidy package did not prove to be suf-
ficient to protect some beneficiaries from impoverish-
ment. Consistent with the study findings, a systematic
review of studies reporting on the impact of health
insurance schemes that were intended to benefit the
poor showed that there was some evidence that health
insurance may prevent high levels of expenditure but it
did not show any correlation with high enrolment in the
schemes with better outcomes [30]. Catastrophic spend-
ing in low- and middle-income countries has been
shown to be positively and strongly correlated with the
availability of health services in the country and with
ageing populations [31]. This is applicable to the study
setting where the main reason for medical travel has
been due to unavailability of health services in the coun-
try. Government subsidy can be an important mechan-
ism to protect households from impoverishment when
appropriate targeting mechanisms are applied.
Strengths and limitations
The sample was derived using a cross-sectional survey
via multiple sources, which helped to acquire many
medical travellers in a short period of time. However it
may have contributed to sampling bias. To avoid estima-
tion bias, stratified samples of subsidized and non-
subsidized travellers for the strata sizes were calculated
which also allowed the application of different measure-
ment techniques such as telephone interviews and face
to face interviews whichever was most viable for each
stratum. The quality of the consumption data on house-
holds is weak as the sub aggregates were too limited.
Data on detailed consumption sub aggregates would
have provided more information such as expenditures
on inpatient care, outpatient, and drugs instead of a total
health expenditure value. In addition, data were based
on self-reports which could not be verified and which
may have led to under reporting of income and over
reporting of expenditures.
Conclusion
Evidence of a strong association between predominant
public financing of medical travel and equality was
found. With universal eligibility to government subsidy
for medical travel, utilization of treatment abroad,
medical expenditures abroad and OOP expenditures on
health among Maldivian medical travellers were similar
between the poor and the rich. We conclude mixed evi-
dence on the linkages between public financing of med-
ical travel and impoverishment. Despite the fact that
they bear the highest cost of treatment abroad, very low
levels of impoverishment were observed among patients
seeking treatment for neoplasms, for which more than
85 % of the patients received the government subsidy. In
comparison, other disease groups had high levels of
impoverishment where the number of beneficiaries was
comparatively low. However, the proportion of subsi-
dised travellers suffering from impoverishment was
higher than that of the non-subsidized group which calls
for more evidence to identify reasons why people do not
seek the public subsidy for medical travel and the health
seeking behaviours of the subsidized and the non-
subsidized traveller. There is need for further research to
examine differences in impoverishment levels between
households with and without medical travel and investi-
gate the relationship between public subsidy for medical
travel and impoverishment.
Endnotes
1The poverty headcount measures the proportion of
the population that is poor, defined as falling below the
poverty line.
2The poverty gap measures the extent to which indi-
viduals fall below the poverty line, measuring the depth
of poverty as well as the incidence line [13].
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